(Q34387086)

English

New devices in heart failure: an European Heart Rhythm Association report: developed by the European Heart Rhythm Association; endorsed by the Heart Failure Association

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

New devices in heart failure: an European Heart Rhythm Association report: developed by the European Heart Rhythm Association; endorsed by the Heart Failure Association (English)

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

0 references

Kenneth Dickstein

13

object named as

Kenneth Dickstein

0 references

Giuseppe Boriani

object named as

Giuseppe Boriani

4

0 references

Paulus Kirchhof

object named as

Paulus Kirchhof

11

0 references

Frank Ruschitzka

17

object named as

Frank Ruschitzka

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

16

object named as

Luigi Tavazzi

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Karl-Heinz Kuck

1

object named as

Karl-Heinz Kuck

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

15

object named as

Cecilia Linde

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Patrick Schauerte

7

object named as

Patrick Schauerte

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Martin Borggrefe

3

object named as

Martin Borggrefe

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

8

object named as

Dominic Theuns

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

author name string

Pierre Bordachar

2

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Haran Burri

5

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Francisco Leyva

6

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Bernard Thibault

9

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Document Reviewers

10

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Gerhard Hasenfuss

12

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Christophe Leclercq

14

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

publication date

20 November 2013

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

16

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

109-128

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

2012 EHRA/HRS expert consensus statement on cardiac resynchronization therapy in heart failure: implant and follow-up recommendations and management

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT311

21 January 2018

2013 ESC guidelines on cardiac pacing and cardiac resynchronization therapy: the task force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Associ

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT311

21 January 2018

Cardiac resynchronization in chronic heart failure

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT311

21 January 2018

Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT311

21 January 2018

EURObservational Research Programme: the Heart Failure Pilot Survey (ESC-HF Pilot).

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT311

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT311

21 January 2018

Electrical signals applied during the absolute refractory period: an investigational treatment for advanced heart failure in patients with normal QRS duration

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT311

21 January 2018

Cardiac contractility modulation with the impulse dynamics signal: studies in dogs with chronic heart failure

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT311

21 January 2018

Cardiac contractility modulation by electric currents applied during the refractory period

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT311

21 January 2018

Therapy with cardiac contractility modulation electrical signals improves left ventricular function and remodeling in dogs with chronic heart failure

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT311

21 January 2018

Cardiac contractility modulation by electric currents applied during the refractory period in patients with heart failure secondary to ischemic or idiopathic dilated cardiomyopathy

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT311

21 January 2018

Electrical modulation of cardiac contractility: clinical aspects in congestive heart failure.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT311

21 January 2018

Enhanced inotropic state of the failing left ventricle by cardiac contractility modulation electrical signals is not associated with increased myocardial oxygen consumption.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT311

21 January 2018

First human chronic experience with cardiac contractility modulation by nonexcitatory electrical currents for treating systolic heart failure: mid-term safety and efficacy results from a multicenter study.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT311

21 January 2018

Impact of cardiac contractility modulation on left ventricular global and regional function and remodeling.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT311

21 January 2018

Initial interactions in electromagnetic field-induced biosynthesis

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT311

21 January 2018

Cardiac contractility modulation electrical signals improve myocardial gene expression in patients with heart failure

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT311

21 January 2018

Chronic electrical stimulation during the absolute refractory period of the myocardium improves severe heart failure

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT311

21 January 2018

Nonexcitatory, cardiac contractility modulation electrical impulses: feasibility study for advanced heart failure in patients with normal QRS duration

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT311

21 January 2018

Randomized, double blind study of non-excitatory, cardiac contractility modulation electrical impulses for symptomatic heart failure

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT311

21 January 2018

A randomized controlled trial evaluating the safety and efficacy of cardiac contractility modulation in advanced heart failure

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT311

21 January 2018

"Responder analysis" for assessing effectiveness of heart failure therapies based on measures of exercise tolerance

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT311

21 January 2018

Subgroup analysis of a randomized controlled trial evaluating the safety and efficacy of cardiac contractility modulation in advanced heart failure

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT311

21 January 2018

Long-term outcome of cardiac contractility modulation in patients with severe congestive heart failure

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT311

21 January 2018

Cardiac contractility modulation in non-responders to cardiac resynchronization therapy

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT311

21 January 2018

Parasympathetic withdrawal is an integral component of autonomic imbalance in congestive heart failure: demonstration in human subjects and verification in a paced canine model of ventricular failure

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT311

21 January 2018

Sympathetic-parasympathetic interaction in health and disease: abnormalities and relevance in heart failure

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT311

21 January 2018

Heart rate turbulence predicts all-cause mortality and sudden death in congestive heart failure patients

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT311

21 January 2018

beta-Blocker therapy in heart failure: scientific review

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT311

21 January 2018

The problem of chronic refractory angina; report from the ESC Joint Study Group on the Treatment of Refractory Angina

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT311

21 January 2018

Spinal cord stimulation in chronic intractable angina pectoris: a randomized, controlled efficacy study.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT311

21 January 2018

Spinal-cord stimulation in management of angina

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT311

21 January 2018

Effect of spinal cord stimulation on spontaneous and stress-induced angina and 'ischemia-like' ST-segment depression in patients with cardiac syndrome X.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT311

21 January 2018

Successful use of spinal cord stimulation in the treatment of severe Raynaud's disease of the hands.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT311

21 January 2018

Spinal cord stimulation and cerebral hemodynamics: updated mechanism and therapeutic implications

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT311

21 January 2018

Spinal cord stimulation for chronic intractable angina pectoris: a unified theory on its mechanism

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT311

21 January 2018

An open label, single-centre, randomized trial of spinal cord stimulation vs. percutaneous myocardial laser revascularization in patients with refractory angina pectoris: the SPiRiT trial

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT311

21 January 2018

Pain mechanisms: a new theory

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT311

21 January 2018

Putative mechanisms behind effects of spinal cord stimulation on vascular diseases: a review of experimental studies

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT311

21 January 2018

A mechanism of cardiac pain suppression by spinal cord stimulation: implications for patients with angina pectoris

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT311

21 January 2018

[Increased myocardial blood flow after spinal cord stimulation in patients with refractory angina pectoris].

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT311

21 January 2018

Symptomatic relief precedes improvement of myocardial blood flow in patients under spinal cord stimulation

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT311

21 January 2018

Parasympathetic nervous system and heart failure: pathophysiology and potential implications for therapy

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT311

21 January 2018

Dorsal spinal cord stimulation obtunds the capacity of intrathoracic extracardiac neurons to transduce myocardial ischemia

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT311

21 January 2018

Long-term modulation of the intrinsic cardiac nervous system by spinal cord neurons in normal and ischaemic hearts.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT311

21 January 2018

Spinal cord activation differentially modulates ischaemic electrical responses to different stressors in canine ventricles

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT311

21 January 2018

Modulation of intrinsic cardiac neurons by spinal cord stimulation: implications for its therapeutic use in angina pectoris

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT311

21 January 2018

Neuromodulation targets intrinsic cardiac neurons to attenuate neuronally mediated atrial arrhythmias

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT311

21 January 2018

Spinal cord stimulation causes potentiation of right vagus nerve effects on atrial chronotropic function and repolarization in canines

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT311

21 January 2018

A polymorphism of the endothelial nitric oxide synthase promoter is associated with an increase in autonomic imbalance in patients with congestive heart failure

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT311

21 January 2018

Nitric oxide facilitates vagal control of heart rate via actions in the cardiac parasympathetic ganglia of the anaesthetised dog.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT311

21 January 2018

Inflammatory cytokines and nitric oxide in heart failure and potential modulation by vagus nerve stimulation

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT311

21 January 2018

Spinal cord stimulation treatment for angina pectoris: more than a placebo?

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT311

21 January 2018

Thoracic spinal cord stimulation reduces the risk of ischemic ventricular arrhythmias in a postinfarction heart failure canine model

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT311

21 January 2018

Spinal cord stimulation improves ventricular function and reduces ventricular arrhythmias in a canine postinfarction heart failure model.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT311

21 January 2018

NANS Training Requirements for Spinal Cord Stimulation Devices: Selection, Implantation, and Follow-up.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT311

21 January 2018

Spinal cord stimulation: a basic approach

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT311

21 January 2018

Peripheral nerve stimulation or is it peripheral subcutaneous field stimulation; what is in a moniker?

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT311

21 January 2018

Spinal cord stimulation: a 20-year retrospective analysis in 260 patients

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT311

21 January 2018

Retrospective review of 707 cases of spinal cord stimulation: indications and complications

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT311

21 January 2018

Feasibility of Spinal Cord Stimulation in Angina Pectoris in Patients with Chronic Pacemaker Treatment for Cardiac Arrhythmias

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT311

21 January 2018

Potential device interaction of a dual chamber implantable cardioverter defibrillator in a patient with continuous spinal cord stimulation.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT311

21 January 2018

Spinal cord stimulation for refractory angina in patients implanted with cardioverter defibrillators: five case reports

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT311

21 January 2018

Simultaneous use of neurostimulators in patients with a preexisting cardiovascular implantable electronic device

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT311

21 January 2018

Effect of cardiac sympathetic nervous activity on mode of death in congestive heart failure.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT311

21 January 2018

Baroreflex activation therapy lowers blood pressure in patients with resistant hypertension: results from the double-blind, randomized, placebo-controlled rheos pivotal trial

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT311

21 January 2018

An implantable carotid sinus baroreflex activating system: surgical technique and short-term outcome from a multi-center feasibility trial for the treatment of resistant hypertension.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT311

21 January 2018

An implantable carotid sinus stimulator for drug-resistant hypertension: surgical technique and short-term outcome from the multicenter phase II Rheos feasibility trial.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT311

21 January 2018

Novel baroreflex activation therapy in resistant hypertension: results of a European multi-center feasibility study

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT311

21 January 2018

Chronic baroreceptor activation enhances survival in dogs with pacing-induced heart failure.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT311

21 January 2018

Chronic electrical stimulation of the carotid sinus baroreflex improves left ventricular function and promotes reversal of ventricular remodeling in dogs with advanced heart failure

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT311

21 January 2018

Carotid baroreceptor stimulation, sympathetic activity, baroreflex function, and blood pressure in hypertensive patients.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT311

21 January 2018

Chronic baroreflex activation: a potential therapeutic approach to heart failure with preserved ejection fraction

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT311

21 January 2018

Ganglionic mechanisms contribute to diminished vagal control in heart failure

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT311

21 January 2018

Prevention of diminished parasympathetic control of the heart in experimental heart failure

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT311

21 January 2018

Vagal nerve stimulation markedly improves long-term survival after chronic heart failure in rats

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT311

21 January 2018

Electrical vagus nerve stimulation for the treatment of chronic heart failure

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT311

21 January 2018

Chronic vagus nerve stimulation improves autonomic control and attenuates systemic inflammation and heart failure progression in a canine high-rate pacing model.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT311

21 January 2018

Effect of autonomic blockade on ventricular refractoriness and atrioventricular nodal conduction in humans. Evidence supporting a direct cholinergic action on ventricular muscle refractoriness.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT311

21 January 2018

Heart rate as a risk factor in chronic heart failure (SHIFT): the association between heart rate and outcomes in a randomised placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT311

21 January 2018

Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT311

21 January 2018

Chronic vagus nerve stimulation: a new and promising therapeutic approach for chronic heart failure

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT311

21 January 2018

Vagal stimulation for heart failure: background and first in-man study

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT311

21 January 2018

Vagus nerve stimulation: from pre-clinical to clinical application: challenges and future directions.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT311

21 January 2018

Catheter ablation of cardiac autonomic nerves for prevention of vagal atrial fibrillation

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT311

21 January 2018

Intra-abdominal vagal blocking (VBLOC therapy): clinical results with a new implantable medical device.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT311

21 January 2018

Continuous autonomic assessment in patients with symptomatic heart failure: prognostic value of heart rate variability measured by an implanted cardiac resynchronization device.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT311

21 January 2018

Heart failure decompensation and all-cause mortality in relation to percent biventricular pacing in patients with heart failure: is a goal of 100% biventricular pacing necessary?

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT311

21 January 2018

Inappropriate implantable cardioverter-defibrillator shocks in MADIT II: frequency, mechanisms, predictors, and survival impact

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT311

21 January 2018

Gross and microscopic anatomy of the human intrinsic cardiac nervous system.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT311

21 January 2018

Catheter stimulation of cardiac parasympathetic nerves in humans: a novel approach to the cardiac autonomic nervous system

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT311

21 January 2018

Excitation properties of the right cervical vagus nerve in adult dogs.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT311

21 January 2018

Determinants and effects of electrical stimulation of the inferior interatrial parasympathetic plexus during atrial fibrillation.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT311

21 January 2018

Large-conductance calcium-activated potassium channels in neonatal rat intracardiac ganglion neurons

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT311

21 January 2018

A comparative study of three techniques for diameter selective fiber activation in the vagal nerve: anodal block, depolarizing prepulses and slowly rising pulses

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT311

21 January 2018

Recruitment and blocking properties of the CardioFit stimulation lead.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT311

21 January 2018

A meta-analysis of remote monitoring of heart failure patients

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT311

21 January 2018

Telemonitoring in patients with heart failure

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT311

21 January 2018

Intrathoracic impedance vs daily weight monitoring for predicting worsening heart failure events: results of the Fluid Accumulation Status Trial (FAST).

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT311

21 January 2018

Clinical utility of intrathoracic impedance monitoring to alert patients with an implanted device of deteriorating chronic heart failure

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT311

21 January 2018

Disease management: remote monitoring in heart failure patients with implantable defibrillators, resynchronization devices, and haemodynamic monitors

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT311

21 January 2018

Combined heart failure device diagnostics identify patients at higher risk of subsequent heart failure hospitalizations: results from PARTNERS HF (Program to Access and Review Trending Information and Evaluate Correlation to Symptoms in Patients Wit

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT311

21 January 2018

Potential value of automated daily screening of cardiac resynchronization therapy defibrillator diagnostics for prediction of major cardiovascular events: results from Home-CARE (Home Monitoring in Cardiac Resynchronization Therapy) study

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT311

21 January 2018

Implant experience with an implantable hemodynamic monitor for the management of symptomatic heart failure.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT311

21 January 2018

Randomized controlled trial of an implantable continuous hemodynamic monitor in patients with advanced heart failure: the COMPASS-HF study.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT311

21 January 2018

Review of advanced heart failure device diagnostics examined in clinical trials and the potential benefit from monitoring capabilities

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT311

21 January 2018

Implantable sensors for heart failure

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT311

21 January 2018

Intrathoracic Impedance Monitoring in Patients With Heart Failure: Correlation With Fluid Status and Feasibility of Early Warning Preceding Hospitalization

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT311

21 January 2018

Direct left atrial pressure monitoring in severe heart failure: long-term sensor performance

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT311

21 January 2018

Direct left atrial pressure monitoring in ambulatory heart failure patients: initial experience with a new permanent implantable device

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT311

21 January 2018

Physician-directed patient self-management of left atrial pressure in advanced chronic heart failure

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT311

21 January 2018

Comparison of a radiofrequency-based wireless pressure sensor to swan-ganz catheter and echocardiography for ambulatory assessment of pulmonary artery pressure in heart failure

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT311

21 January 2018

Wireless pulmonary artery haemodynamic monitoring in chronic heart failure: a randomised controlled trial.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT311

21 January 2018

2010 Focused Update of ESC Guidelines on device therapy in heart failure

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT311

21 January 2018

Letter: Systematic review and meta-analysis of controlled trials assessing spinal cord stimulation for inoperable critical leg ischaemia (Br J Surg 2004; 91: 948-955)

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT311

21 January 2018

Autonomic modulation of electrical restitution, alternans and ventricular fibrillation initiation in the isolated heart

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT311

21 January 2018

Statin Use Is Associated with Reduced All-Cause Mortality after Endovascular Abdominal Aortic Aneurysm Repair

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT311

21 January 2018

Changes in autonomic balance in patients with decompensated chronic heart failure

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT311

21 January 2018

Baroreflex sensitivity and heart-rate variability in prediction of total cardiac mortality after myocardial infarction

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT311

21 January 2018

Baroreflex Sensitivity Predicts Long-Term Cardiovascular Mortality After Myocardial Infarction Even in Patients With Preserved Left Ventricular Function

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT311

21 January 2018

Identifiers

10.1093/EUROPACE/EUT311

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34387086&oldid=1549443701"